MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold System
Peripheral Arterial Disease (PAD) - lesions in superficial femoral and proximal popliteal arteries
Key Facts
About R3 Vascular
R3 Vascular is a clinical-stage medical device company pioneering next-generation bioresorbable scaffold (BRS) technology for peripheral artery disease. Its lead product, the MAGNITUDE BRS, features the thinnest strut profile ever tested in this clinical setting, aiming to combine the mechanical support of a metal stent with the long-term benefits of complete resorption. Led by a seasoned executive team with a strong track record in vascular device development and commercialization, the company is positioned to address a significant unmet need in the large and growing PAD market. R3 Vascular is currently in the clinical development phase and is pre-revenue.
View full company profile